Home/Filings/4/0001127602-25-007521
4//SEC Filing

Crum Brian T 4

Accession 0001127602-25-007521

CIK 0001062822other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:28 PM ET

Size

15.6 KB

Accession

0001127602-25-007521

Insider Transaction Report

Form 4
Period: 2025-02-28
Crum Brian T
SVP, General Counsel & Secr.
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-28+26,097203,594 total
  • Exercise/Conversion

    Common Stock

    2025-02-28+69,387306,437 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2833,45633,457 total
    Common Stock (33,456 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-28+33,456237,050 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2826,0970 total
    Common Stock (26,097 underlying)
  • Tax Payment

    Common Stock

    2025-02-28$0.67/sh45,622$30,567260,815 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-2869,387138,773 total
    Common Stock (69,387 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001792747

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:28 PM ET
Size
15.6 KB